Skip to main content

People in the News: Jan 21, 2010

Premium

The Automation Partnership has appointed Phillip Sefton as commercial director.

Sefton most recently served as vice president of commercial operations at Qiagen, where he was responsible for sales and market development in Europe, Asia, Australia, Africa, and Latin America.

Prior to Qiagen, Phillip spent eight years with Boehringer Mannheim (now part of Roche Diagnostics), where he worked in the company's Biochemical Business Unit and Laboratory Diagnostics Business Division. He also worked as a researcher at Beecham Pharmaceuticals (now GlaxoSmithKline).

Filed under

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.